• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

FDA-approved laser system treats high myopia with astigmatism

Article

The FDA has granted approval for Advanced Medical Optics’ (AMO) STAR S4 IR excimer laser system for the treatment of high myopia and myopic astigmatism.

With the CustomVue wavefront-guided LASIK procedure, indications include the reduction or elimination of myopia and myopic astigmatism from –6 to –11 D with up to –3 D of cylinder. Clinical studies found that at 6 months, in 98.3% of those who received the CustomVue high-myopia treatment vision was corrected to 20/40 or better and in 84.3% it was corrected to 20/20 or better without spectacles or corrective contact lenses, according to AMO.

CustomVue procedures for high myopia will be released to doctors certified in VISX technology over the next several weeks after they have completed the training and certification process.

Related Videos
Video 2 - 1 KOL is featured in, "Advances in Technology for SMILE procedure"
Video 1 - 1 KOL is featured in, "Overview of Small Incision Lenticule Extraction (SMILE)"
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.